These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7899060)

  • 1. [Evaluation of AMI-25 enhanced MR imaging and enhanced helical CT for liver tumors].
    Yamamoto K; Shimizu T; Hiraishi K; Ashina K; Sagami A; Aratake K; Maeda H; Matsui R; Kawai T; Narabayashi I
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Jan; 55(1):1-6. PubMed ID: 7899060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness of superparamagnetic iron oxide particle (AMI-25) enhanced MR imaging for the diagnosis of liver tumors: comparison with contrast enhanced CT].
    Hirohashi S; Hirohashi R; Uchida H; Kachi K; Ohtomo K; Uchiyama G; Niitsu M; Itai Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jul; 54(8):776-83. PubMed ID: 8072868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging.
    Fretz CJ; Stark DD; Metz CE; Elizondo G; Weissleder R; Shen JH; Wittenberg J; Simeone J; Ferrucci JT
    AJR Am J Roentgenol; 1990 Oct; 155(4):763-70. PubMed ID: 2119106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of hepatocellular carcinoma: comparison of dynamic MR imaging with dynamic double arterial phase helical CT.
    Noguchi Y; Murakami T; Kim T; Hori M; Osuga K; Kawata S; Kumano S; Okada A; Sugiura T; Nakamura H
    AJR Am J Roentgenol; 2003 Feb; 180(2):455-60. PubMed ID: 12540451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of superparamagnetic iron oxide particles in the detection of hepatocellular carcinoma by MR imaging].
    Hirohashi S; Uchida H; Ohimichi R; Kitano S; Tanaka M; Ohishi H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Apr; 53(4):469-71. PubMed ID: 8388092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidetector row CT and MR imaging in diagnosing hepatocellular carcinoma.
    Murakami T; Hori M; Kim T; Kawata S; Abe H; Nakamura H
    Intervirology; 2004; 47(3-5):209-26. PubMed ID: 15383731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats].
    Liu X; Xu YK; Huang QL; Wu YK
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1061-5. PubMed ID: 12480574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading.
    Imai Y; Murakami T; Yoshida S; Nishikawa M; Ohsawa M; Tokunaga K; Murata M; Shibata K; Zushi S; Kurokawa M; Yonezawa T; Kawata S; Takamura M; Nagano H; Sakon M; Monden M; Wakasa K; Nakamura H
    Hepatology; 2000 Aug; 32(2):205-12. PubMed ID: 10915725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The magnetic resonance of small hepatocarcinoma. A comparison with echography, computed tomography, digital angiography and computed tomography with lipiodol].
    De Santis M; Cristani A; Cioni G; Casolo A; Canossi G; Ventura E; Romagnoli R
    Radiol Med; 1992 Nov; 84(5):587-95. PubMed ID: 1335589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
    Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
    J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI in the evaluation of hepatocellular nodules: role of pulse sequences and contrast agents.
    Ichikawa T
    Intervirology; 2004; 47(3-5):252-70. PubMed ID: 15383734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.
    Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Sano M; Kato S; Kitamura T; Fatima Z; Fukushima K; Iino H; Mori Y; Fujii H; Araki T
    J Magn Reson Imaging; 2011 Aug; 34(2):326-35. PubMed ID: 21780227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium].
    Finazzo M; Midiri M; Gallo C; Bartolotta TV; Luca A
    Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-course changes of contrast enhancement in iron colloid enhanced MRI in patients with hepatocellular carcinoma.
    Suto Y; Ametani M; Kamba M; Sugihara S
    Br J Radiol; 1996 Mar; 69(819):201-5. PubMed ID: 8800862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging.
    Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Hatanaka Y; Murakami R; Nishiharu T; Takahashi M; Higashida Y; Moribe N
    Radiology; 1995 Apr; 195(1):106-12. PubMed ID: 7892448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
    Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF
    AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of biphasic spiral CT, conventional and iron oxide enhanced MRI on therapy and therapy costs in patients with focal liver lesions].
    Helmberger T; Gregor M; Holzknecht N; Rau H; Scheidler J; Reiser M
    Rofo; 2000 Mar; 172(3):251-9. PubMed ID: 10778456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.